JP2025081323A5 - - Google Patents
Info
- Publication number
- JP2025081323A5 JP2025081323A5 JP2025009888A JP2025009888A JP2025081323A5 JP 2025081323 A5 JP2025081323 A5 JP 2025081323A5 JP 2025009888 A JP2025009888 A JP 2025009888A JP 2025009888 A JP2025009888 A JP 2025009888A JP 2025081323 A5 JP2025081323 A5 JP 2025081323A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962796002P | 2019-01-23 | 2019-01-23 | |
| US62/796,002 | 2019-01-23 | ||
| PCT/US2020/014819 WO2020154520A1 (en) | 2019-01-23 | 2020-01-23 | Methods of treating epilepsy via phosphodiesterase 4 (pde4) inhibition |
| JP2021543315A JP2022518292A (ja) | 2019-01-23 | 2020-01-23 | ホスホジエステラーゼ４（ｐｄｅ４）阻害によるてんかんの治療方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543315A Division JP2022518292A (ja) | 2019-01-23 | 2020-01-23 | ホスホジエステラーゼ４（ｐｄｅ４）阻害によるてんかんの治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025081323A JP2025081323A (ja) | 2025-05-27 |
| JP2025081323A5 true JP2025081323A5 (https=) | 2026-01-20 |
Family
ID=71735544
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543315A Pending JP2022518292A (ja) | 2019-01-23 | 2020-01-23 | ホスホジエステラーゼ４（ｐｄｅ４）阻害によるてんかんの治療方法 |
| JP2025009888A Pending JP2025081323A (ja) | 2019-01-23 | 2025-01-23 | ホスホジエステラーゼ４（ｐｄｅ４）阻害によるてんかんの治療方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543315A Pending JP2022518292A (ja) | 2019-01-23 | 2020-01-23 | ホスホジエステラーゼ４（ｐｄｅ４）阻害によるてんかんの治療方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220098257A1 (https=) |
| EP (1) | EP3914701B1 (https=) |
| JP (2) | JP2022518292A (https=) |
| CN (1) | CN113490739A (https=) |
| CA (1) | CA3127357A1 (https=) |
| WO (1) | WO2020154520A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201911603D0 (en) * | 2019-08-14 | 2019-09-25 | Healx Ltd | Treatment |
| EP4001923B1 (en) | 2020-11-23 | 2024-06-05 | Roche Diagnostics GmbH | Laboratory sample distribution system and laboratory automation system |
| EP4249607A1 (en) * | 2022-03-21 | 2023-09-27 | Warszawski Uniwersytet Medyczny | Panel of markers for prediction of epilepsy recurrence in patients with tuberous sclerosis and the uses thereof |
| CN121022847B (zh) * | 2025-10-31 | 2026-02-06 | 温州医科大学附属眼视光医院 | 一种敲除斑马鱼pde6a的sgRNA及其在视觉疾病中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1414841B1 (en) * | 2001-07-10 | 2012-11-14 | Lakewood-Amedex, Inc | Oligonucleotide-containing pharmacological compositions and their use |
| US20050164275A1 (en) * | 2002-10-18 | 2005-07-28 | Incyte Corporation | Phosphodiesterases |
| WO2006050057A2 (en) * | 2004-10-28 | 2006-05-11 | Celgene Corporation | Methods and compositions using pde4 modulators for treatment and management of central nervous system injury |
| JP2009509984A (ja) * | 2005-09-29 | 2009-03-12 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | 泌尿器系障害の処置用のｐｄｅ阻害剤およびそれらの組合せ |
| CA2657093A1 (en) * | 2006-07-07 | 2008-01-10 | Steven P. Govek | Bicyclic heteroaryl inhibitors of pde4 |
| EP2334180A4 (en) * | 2008-09-15 | 2013-07-03 | Univ California | RESTRICTING DISEASES WITH A COMBINATION OF ACTIVE SUBSTANCES TO INCREASE THE CONCENTRATION OF EPOXYGENATED FATTY ACIDS AND ACTIVE SUBSTANCES TO INCREASE THE CAMP CONCENTRATION |
| US20130065936A1 (en) * | 2010-05-14 | 2013-03-14 | The Regents Of The University Of California | Modulation of bioactive epoxy-fatty acid levels by phosphodiesterase inhibitors |
| US20130252924A1 (en) * | 2010-11-11 | 2013-09-26 | Akron Molecules Gmbh | Compounds and Methods for Treating Pain |
| US8865723B2 (en) * | 2012-10-25 | 2014-10-21 | Tetra Discovery Partners Llc | Selective PDE4 B inhibition and improvement in cognition in subjects with brain injury |
| WO2014083099A1 (en) * | 2012-11-30 | 2014-06-05 | Leo Pharma A/S | A method of inhibiting the expression of il-22 in activated t-cells |
| CN107787322B (zh) * | 2015-06-17 | 2023-07-07 | 辉瑞大药厂 | 三环化合物以及它们作为磷酸二酯酶抑制剂的用途 |
| CN113332292A (zh) * | 2016-02-23 | 2021-09-03 | 辉瑞公司 | 6,7-二氢-5H-吡唑并[5,1-b][1,3]噁嗪-2-甲酰胺化合物 |
-
2020
- 2020-01-23 CA CA3127357A patent/CA3127357A1/en active Pending
- 2020-01-23 JP JP2021543315A patent/JP2022518292A/ja active Pending
- 2020-01-23 US US17/424,055 patent/US20220098257A1/en active Pending
- 2020-01-23 CN CN202080013929.1A patent/CN113490739A/zh active Pending
- 2020-01-23 WO PCT/US2020/014819 patent/WO2020154520A1/en not_active Ceased
- 2020-01-23 EP EP20744495.1A patent/EP3914701B1/en active Active
-
2025
- 2025-01-23 JP JP2025009888A patent/JP2025081323A/ja active Pending